As therapy for locoregionally advanced head and neck cancer (HNC) has evolved, treatment
has become increasingly aggressive and cure rates have risen. However, survival still …

Locally advanced stages of squamous cancers of the head and neck (LAHNCs) acquire
high propensity for local and systemic relapse. Addition of systemic therapy as an induction …

Locally advanced squamous cell cancer of the head and neck is a major contributor to
morbidity and mortality worldwide. Despite progress through the use of multimodality …

As a component of multimodal therapy in locally advanced head and neck cancer, induction
chemotherapy represents a strategy to reduce tumor burden and target distant metastases …

Chemoradiotherapy as an alternative to surgery can be offered to patients affected by loco-
regionally advanced head and neck cancer (HNC). Induction chemotherapy is a valid …

Advanced locoregional disease is the most frequent clinical situation in Head and Neck
cancer. The standard of care for most clinicians is a multidisciplinary treatment with …

Despite several decades of intensive investigation, the optimal sequencing of
chemotherapy, radiation, and surgery in the management of locoregionally advanced head …

The addition of chemotherapy to radiotherapy in the treatment of locally advanced
squamous cell carcinoma of the head and neck (SCCHN) patients improves survival. Meta …

The treatment of patients with locoregionally advanced squamous cell cancer of the head
and neck is still evolving. Induction chemotherapy (IC) is widely used in this patient …

Locally advanced squamous cell head and neck cancer remains a therapeutic challenge for
multidisciplinary teams. Despite high objective response rates, induction chemotherapy has …